ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

June 30, 2010

Conditions
Myocardial Ischemia
Trial Locations (23)

15213

University of Pittsburgh Medical Center, Pittsburgh

55407

Minneapolis Heart Institute, Minneapolis

92037

Scripps Green Hospital / Scripps Clinical Hospital, La Jolla

Unknown

Cardiology, PC, Birmingham

Mayo Clinic Hospital, Phoenix

Stanford University Hospital and Clinics, Stanford

Washington Hospital Center, Washington D.C.

Holy Cross Hospital, Fort Lauderdale

University of Florida, Gainesville

University of Florida Health Science Center, Jacksonville

Cardiovascular Institute Florida Hospital, Orlando

The Medical Group of St. Joseph´s, Atlanta

Northwestern University Medical School, Chicago

Rush University Medical Center, Chicago

University of Iowa, Iowa City

Caritas St. Elizabeth´s Medical Center, Boston

Massachusetts General Hospital, Boston

Cornell University, New York

New York Presbyterian Hospital, New York

The Lindner Clinical Trial Center, Cincinnati

University of Cincinnati Medical Center, Cincinnati

University of Wisconsin Medical School, Madison

Heart Care Associates, LLC, Milwaukee

Sponsors
All Listed Sponsors
lead

Lisata Therapeutics, Inc.

INDUSTRY

NCT00545610 - ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study) | Biotech Hunter | Biotech Hunter